It was reported the patient had instent restenosis of the study stent.The patient was enrolled in the (b)(6) study on (b)(6) 2016 and the index procedure was performed on the same day.The target lesion one was located in the right leg mid superficial femoral artery (sfa) extending to the distal sfa with 70% stenosis and was 106 mm long with a proximal reference vessel diameter of 5.3 mm and distal vessel diameter of 5.8 mm and was classified as tasc ii b lesion.The lesion was treated with pre-dilatation and a 7.00x120mm study stent was placed.Following post-dilatation, residual stenosis was 19%.On (b)(6) 2017, 368 days post index procedure, during the 12 month study specific follow up, dus was performed and the subject was diagnosed with 50-99% instent restenosis of the study stent placed in the right sfa.On (b)(6) 2018, during the 24 month study specific follow up, dus was performed and the subject was diagnosed with 50-99% instent restenosis of the study stent placed in the right sfa.No reported action was taken.
|